GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cardiovascular Systems Inc (FRA:R7Y1) » Definitions » Cyclically Adjusted Revenue per Share

Cardiovascular Systems (FRA:R7Y1) Cyclically Adjusted Revenue per Share : €0.00 (As of Dec. 2022)


View and export this data going back to 2012. Start your Free Trial

What is Cardiovascular Systems Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Cardiovascular Systems's adjusted revenue per share for the three months ended in Dec. 2022 was €1.463. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €0.00 for the trailing ten years ended in Dec. 2022.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-05-23), Cardiovascular Systems's current stock price is €18.00. Cardiovascular Systems's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2022 was €0.00. Cardiovascular Systems's Cyclically Adjusted PS Ratio of today is .


Cardiovascular Systems Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Cardiovascular Systems's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiovascular Systems Cyclically Adjusted Revenue per Share Chart

Cardiovascular Systems Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cardiovascular Systems Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cardiovascular Systems's Cyclically Adjusted Revenue per Share

For the Medical Devices subindustry, Cardiovascular Systems's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardiovascular Systems's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cardiovascular Systems's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Cardiovascular Systems's Cyclically Adjusted PS Ratio falls into.



Cardiovascular Systems Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cardiovascular Systems's adjusted Revenue per Share data for the three months ended in Dec. 2022 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2022 (Change)*Current CPI (Dec. 2022)
=1.463/125.2218*125.2218
=1.463

Current CPI (Dec. 2022) = 125.2218.

Cardiovascular Systems Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201303 0.951 98.209 1.213
201306 0.904 98.518 1.149
201309 0.900 98.790 1.141
201312 0.869 98.326 1.107
201403 0.832 99.695 1.045
201406 0.941 100.560 1.172
201409 1.025 100.428 1.278
201412 1.152 99.070 1.456
201503 1.372 99.621 1.725
201506 1.360 100.684 1.691
201509 1.214 100.392 1.514
201512 1.167 99.792 1.464
201603 1.221 100.470 1.522
201606 1.320 101.688 1.625
201609 1.345 101.861 1.653
201612 1.446 101.863 1.778
201703 1.493 102.862 1.818
201706 1.436 103.349 1.740
201709 1.264 104.136 1.520
201712 1.343 104.011 1.617
201803 1.340 105.290 1.594
201806 1.441 106.317 1.697
201809 1.443 106.507 1.697
201812 1.551 105.998 1.832
201903 1.636 107.251 1.910
201906 1.797 108.070 2.082
201909 1.729 108.329 1.999
201912 1.805 108.420 2.085
202003 1.621 108.902 1.864
202006 1.079 108.767 1.242
202009 1.329 109.815 1.515
202012 1.359 109.897 1.549
202103 1.366 111.754 1.531
202106 1.465 114.631 1.600
202109 1.269 115.734 1.373
202112 1.335 117.630 1.421
202203 1.299 121.301 1.341
202206 1.443 125.017 1.445
202209 1.522 125.227 1.522
202212 1.463 125.222 1.463

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Cardiovascular Systems  (FRA:R7Y1) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Cardiovascular Systems Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Cardiovascular Systems's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardiovascular Systems (FRA:R7Y1) Business Description

Traded in Other Exchanges
N/A
Address
1225 Old Highway 8 Northwest, Saint Paul, MN, USA, 55112-6416
Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generate the vast majority of its revenue in the United States.

Cardiovascular Systems (FRA:R7Y1) Headlines

No Headlines